Outcome of two patients harboring EML4-ALK fusion gene with brain metastasis treated with crizotinib

被引：0
|
作者：
Okimoto, Tamio [1 ]
Tsubata, Yukari [1 ]
Nakao, Mika [1 ]
Koba, Naoya [1 ]
Hotta, Takamasa [1 ]
Hamaguchi, Megumi [1 ]
Hamaguchi, Shunnichi [1 ]
Sutani, Akihisa [1 ]
Hamada, Akinobu [2 ]
Isobe, Takeshi [1 ]
机构：
[1] Shimane Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Resp Med, Matsue, Shimane, Japan
[2] Natl Canc Ctr, Res Inst, Ctr Translat Res Core, Dept Clin Pharmacol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-1-56
引用
下载
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [1] A CASE OF LUNG ADENOCARCINOMA RESISTANT TO CRIZOTINIB HARBORING KRAS MUTATION AND EML4-ALK FUSION GENE
    Anai, Satoshi
    Suzuki, Kunihiro
    Sueishi, Katsuo
    Harada, Taishi
    Toyokawa, Gouji
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Takayama, Koichi
    Ichinose, Yukito
    Nakanishi, Yoichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB
    Menefee, Michael E.
    D'Amico, Thomas A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1315 - S1316
  • [3] A case of inflammatory myofibroblastic tumor harboring EML4-ALK fusion with a brain metastasis responding to alectinib
    Sakoda, Soichiro
    Tanaka, Kentaro
    Koga, Yuichiro
    Mikumo, Hironori
    Tsuchiya-Kawano, Yuko
    Harada, Eiji
    Tamiya, Sadafumi
    Okamoto, Isamu
    THORACIC CANCER, 2024, 15 (05) : 415 - 418
  • [4] Clinical effect of crizotinib on lung cancer patients with EML4-ALK fusion gene mutation
    Wang, Zhiyong
    Wang, Wei
    Kong, Xiaodong
    Li, Guangxu
    Yang, Weiwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11632 - 11638
  • [5] Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib
    Saraceni, Christine
    Li, P. Mark
    Gainor, Justin F.
    Stopyra, Gary A.
    Friedman, Eliot L.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : 1116 - 1117
  • [6] Pulmonary Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene
    Sokai, Akihiko
    Enaka, Makiko
    Sokai, Risa
    Mori, Shoichi
    Mori, Shunsuke
    Gunji, Masaharu
    Fujino, Masahiko
    Ito, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 93 - 96
  • [7] A Case of Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion with Partial Response to Crizotinib
    Shen, Qian
    Kalyani, Farhin Shaheed
    Qu, Jingjing
    Chen, Zhen
    Zhang, Jing
    Zhou, Jianying
    CLINICAL LUNG CANCER, 2021, 22 (06) : E799 - E803
  • [8] Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung
    Batra, U.
    Sharma, M.
    Jain, A.
    Agarwal, M.
    Goyal, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
    Tanaka, Hisashi
    Hayashi, Akihito
    Morimoto, Takeshi
    Taima, Kageaki
    Tanaka, Yoshihito
    Shimada, Michiko
    Kurose, Akira
    Takanashi, Shingo
    Okumura, Ken
    BMC CANCER, 2012, 12
  • [10] Primary lung adenocarcinoma with breast metastasis harboring the EML4-ALK fusion: A case report
    Zhang, Wenwen
    Zhang, Yu
    Zhou, Lei
    Tan, Na
    Bai, Yuju
    Xing, Shiyun
    ONCOLOGY LETTERS, 2024, 27 (06)
12345